{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["Table 1"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Table 1","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"merged":[[0,0,0,4],[1,0,1,1],[2,0,2,1],[3,0,3,1],[4,0,4,1],[5,0,5,1],[6,0,6,1],[7,0,7,1],[8,0,8,1],[9,0,9,1],[10,0,10,1],[11,0,11,1],[12,0,12,1],[13,0,13,1],[14,0,14,1],[15,0,15,1],[16,0,16,1],[17,0,17,1],[18,0,21,0],[22,0,22,1],[23,0,23,1],[24,0,24,4]],"flags":["formulas_cached_only"]}
["Table 1: Baseline characteristics of the included patients"]
[null,null,"Iron supplementation group (N=15)","NYT group (N=15)","P value"]
["Age — years",null,"45.1 ± 7.7","41.1 ± 8.3",0.52]
["Body mass index — kg/m2",null,"21.4 ± 2.6","22.6 ± 2.7",0.27]
["Duration of intervention — days",null,"39.7 ± 23.0","39.9 ± 20.3",0.88]
["Disease — N (%)",{"$nulls":3},1]
["Benign ",null,"10 (67)","11 (73)"]
["Malignant",null,"5 (33)","4 (27)"]
["Menstruation — N (%)",{"$nulls":3},1]
["+",null,"14 (93)","15 (100)"]
["-",null,"1 (7)","0 (0)"]
["Hormonal therapy — N (%)",{"$nulls":3},0.68]
["+",null,"5 (33)","3 (20)"]
["-",null,"10 (67)","12 (80)"]
["Hemoglobin — g/dL",null,"9.9 ± 0.8","9.8 ± 1.0",0.59]
["Hematocrit — %",null,"32.3 ± 2.1","32.7 ± 2.1",0.77]
["Median serum iron level (IQR) — µg/dL",null,"27 (14, 84) $","32 (15, 146) #",0.88]
["Median ferritin (IQR) — ng/mL",null,"10 (5, 22) $","4 (3, 10) #",0.18]
["CFS","Physical","5.9 ± 5.1","7.1 ± 5.4",0.4]
[null,"Affective","6.5 ± 3.0","7.9 ± 4.1",0.38]
[null,"Cognitive","3.5 ± 3.7","2.8 ± 2.8",0.92]
[null,"Total","15.9 ± 9.3","17.9 ± 10.2",0.66]
["Median VAS-A (IQR) — mm",null,"50 (8, 65)","56 (50, 70)",0.38]
["Median PSQI (IQR)",null,"4 (3, 5)","5 (3, 7)",0.37]
["Plus-minus values are mean ± standard deviation; analyzed with Wilcoxon rank sum test or Fisher’s exact test; CFS, cancer fatigue scale; VAS-A, visual analogue scale for anxiety; PSQI, Pittsburgh sleep quality index; IQR, interquartile range; $, N=9; #, N=8"]